Self evaluation of side-effects of patients treated sequentially with sunitinib and sorafenib in kidney cancer

被引：0
|
作者：
Plantade, A. [1 ]
Leborgne, S. [1 ]
Massard, C. [1 ]
Fizazi, K. [1 ]
Escudier, B. [1 ]
机构：
[1] Inst Gustave Roussy, Villejuif, France
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71156-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4525
引用
收藏
页码：306 / 306
页数：1
相关论文
共 50 条
  • [1] Cutaneous side effects of sorafenib and sunitinib
    Autier, J.
    Mateus, C.
    Wechsler, J.
    Spatz, A.
    Robert, C.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2008, 135 (02): : 148 - 153
  • [2] National survey for patients on the side effects of oral anticancer drugs indicated in kidney cancer (axitinib, sorafenib, sunitinib, pazopanib, everolimus)
    Negellen, S.
    Gannac, M-S.
    De Peretti, C.
    Morel, D.
    Finzi, J.
    Belorgey, C.
    BULLETIN DU CANCER, 2016, 103 (06) : S112 - S112
  • [3] Hypothyroidism Side Effect in Patients Treated with Sunitinib or Sorafenib: Clinical and Structural Analyses
    Shu, Mao
    Zai, Xiaoli
    Zhang, Beina
    Wang, Rui
    Lin, Zhihua
    PLOS ONE, 2016, 11 (01):
  • [4] OTOTOXIC SIDE-EFFECTS IN OVARIAN-CANCER PATIENTS TREATED WITH CISPLATINUM
    BEHLING, H
    SPIESKE, C
    KRAFFT, W
    ZENTRALBLATT FUR GYNAKOLOGIE, 1988, 110 (05): : 277 - 282
  • [5] Influenza vaccine shown to be effective in cancer patients treated with sunitinib and sorafenib
    不详
    EXPERT REVIEW OF VACCINES, 2011, 10 (09) : 1259 - 1259
  • [6] Thyroid Dysfunction in Patients Treated With Sunitinib or Sorafenib
    Clemons, Julia
    Gao, Dexiang
    Naam, Mary
    Breaker, Kathryn
    Garfield, David
    Flaig, Thomas W.
    CLINICAL GENITOURINARY CANCER, 2012, 10 (04) : 225 - 231
  • [7] Cutaneous side effects of the multikinase inhibitors sorafenib and sunitinib
    Wollenberg, A.
    Staehler, M.
    Eames, T.
    HAUTARZT, 2010, 61 (08): : 662 - 667
  • [8] Correlation of hypothyroidism with survival in metastatic renal cancer patients treated with sorafenib or sunitinib
    Riesenbeck, L.
    Bierer, S.
    Hoffmeister, I.
    Koepke, T.
    Hertle, L.
    Thielen, B.
    Herrmann, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [9] EVALUATION OF SIDE-EFFECTS
    VONEICKSTEDT, KW
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1975, 25 (NA7): : 1223 - 1226
  • [10] Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib
    Lee, W. J.
    Lee, J. L.
    Chang, S. E.
    Lee, M. W.
    Kang, Y. K.
    Choi, J. H.
    Moon, K. C.
    Koh, J. K.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (05) : 1045 - 1051
12345